Performance of ASCVD Risk Prediction Models in Individuals With Inflammatory Bowel Disease: A UK Biobank Study.

This study suggests that the current atherosclerotic cardiovascular disease risk prediction models used in clinical practice performed better in the non­inflammatory bowel disease (IBD) cohort compared with IBD, highlighting the need for a more specific risk prediction model tailored to the IBD population.